Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...
Egile Nagusiak: | Antoniades, C, Lee, R, Kohler, M, Stradling, J |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
European Respiratory Society
2016
|
Antzeko izenburuak
-
Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress
nork: Turnbull, C, et al.
Argitaratua: (2016) -
The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
nork: Turnbull, C, et al.
Argitaratua: (2016) -
Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
nork: Schwarz, E, et al.
Argitaratua: (2016) -
Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
nork: Lettau, F, et al.
Argitaratua: (2017) -
Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
nork: Schwarz, E, et al.
Argitaratua: (2016)